ArticleFrontiers in neurology
Assessment value of blood pressure variability combined with serum tau protein for the prognosis of patients with traumatic brain injury.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the prognostic value of blood pressure variability (BPV) combined with serum tau protein in patients with traumatic brain injury (TBI). Methods: A total of 205 TBI patients were prospectively enrolled and categorized into mild, moderate, and severe groups based on their Glasgow Coma Scale (GCS) scores at admission. BPV [coefficient of variation for systolic and diastolic blood pressure (CV-SBP, CV-DBP)] and serum tau protein levels were measured. Their correlations with disease severity and 28-day prognosis were analyzed. Univariate and multivariable logistic regression analyses identified prognostic factors, and receiver operating characteristic (ROC) curves evaluated the predictive performance of individual indicators and their combination. Results: Levels of CV-SBP, CV-DBP, and tau protein significantly increased with TBI severity (all Conclusion: Both BPV and serum tau protein are reliable predictors of severity and poor prognosis in TBI patients. Their combination demonstrates superior incremental predictive performance compared with any single indicator in this cohort, but requires external validation before clinical implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.